Description
PRINCIPIO ACTIVO: HIALURONATO DE SODIO 4MG
Vía de administración: Oftálmica
La dosis y esquema deben ser determinados por el oncólogo tratante
267M2007 SSA
ONICIT 0.05MG/ML SOL INY FA 1.5ML ALUMINIO 3.50 G OXIDO DE ZINC 18.00 G LIDOCAINA 5.00 G HIDROCORTISONA 0.25 G PRINCIPIO ACTIVO: HIALURONATO DE SODIOSolucin Frasco mpula C 1. 5 ml
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
